Chapter 11 Lewy Body Dementia

International Review of Neurobiology

Volumn 84, Issue , 2009, Pages 215-228

  Hanson, Jennifer C ^a   Lippa, Carol F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CLONAZEPAM; LEVODOPA; MELATONIN; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; UBIQUITIN;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; CLINICAL FEATURE; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; REM BEHAVIOR DISORDER; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; GENETICS; PATHOLOGY;

HUMANS; LEWY BODY DISEASE;

EID: 66249088326     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(09)00411-5     Document Type: Review

References (44)

1. Aarsland D., Litvan I., Salmon D., Galasko D., Wentzel-Larsen T., and Larsen J.P. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr. 74 9 (2003) 1215-1220
2. Aarsland D., Perry R., Larsen J.P., McKeith I.G., O'Brien J.T., Perry E.K., Burn D., and Ballard C.G. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J. Clin. Psychiatr. 66 5 (2005) 633-637
3. Aarsland D., Kurz M., Beyer M., Bronnick K., Pippenstock N., and Ballard C. Early discriminatory diagnosis of dementia with Lewy bodies. The emerging role of CSF and imaging biomarkers. Dement. Geriatr. Cogn. Disord. 25 3 (2008) 195-205
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV TR). 4th ed. Vol 157 (2004), American Psychiatric Association, Arlington, VA 3rd revision
5. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., and Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152 4 (1998) 879-884
6. Ballard C.G., Chalmers K.A., Todd C., McKeith I.G., OBrien J.T., Wilcock G., Love S., and Perry E.K. Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology 68 20 (2007) 1726-1729
7. Barber R., Panikkar A., and McKeith I.G. Dementia with Lewy bodies: Diagnosis and management. Int. J. Geriatr. Psychiatr. 16 (2001) S12-S18
8. Boeve B.F., Silber M.H., and Ferman T.J. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J. Geriatr. Psychiatr. Neurol. 17 3 (2004) 146-157
9. Boeve B.F., Silber M.H., Saper C.B., Ferman T.J., Dickson D.W., Parisi J.E., Benarroch E.E., Ahlskog J.E., Smith G.E., Caselli R.C., Tippman-Peikert M., et al. Pathophysiology of REM sleep behavior disorder and relevance to neurodegenerative disease. Brain 130 Pt. 11 (2007) 2770-2788
10. Burn D.J., and McKeith I.G. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov. Disord. 18 Suppl. 6 (2003) S72-S79
11. Burn D.J., Rowan E.N., Minett T., Sanders J., Myint P., Richardson J., Thomas A., Newby J., Reid J., OBrien J.T., and McKeith I.G. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov. Disord. 18 8 (2003) 884-889
12. Connor D.J., Salmon D.P., Sandy T.J., Galasko D., Hansen L.A., and Thal L.J. Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Arch. Neurol. 55 7 (1998) 994-1000
13. Duda J.E., Giasson B.I., Mabon M.E., Lee V.M., and Trojanowski J.Q. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann. Neurol. 52 2 (2002) 205-210
14. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., Broe G.A., Cummings J., Dickson D.W., Gauthier S., Goldman J., Goetz C., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord. 22 12 (2007) 1689-1707
15. Fahn S., Elton R.L., and UPDRS program members. Unified Parkinson's disease rating scale. In: Fahn S., Marsden C.D., Goldstein M., and Calne D.B. (Eds). Recent Developments in Parkinsons Disease Vol. 2 (1987), Macmillan Healthcare Information, Florham Park, NJ 153-163
16. Fantini M.L., Ferini-Strambi L., and Montplaisir J. Idiopathic REM sleep behavior disorder: Toward a better nosologic definition. Neurology 64 (2005) 780-786
17. Hamilton R.L. Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 10 3 (2000) 378-384
18. Harding A.J., and Halliday G.M. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol. 102 (2001) 355-363
19. Harding A.J., Broe G.A., and Halliday G.M. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125 Pt. 2 (2002) 391-403
20. Janvin C.C., Larsen J.P., Salmon D.P., Galasko D., Hugdahl K., and Aarsland D. Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with lewy bodies and Alzheimer's disease. Mov. Disord. 21 3 (2006) 337-342
21. Kramer M.L., and Schulz-Schaeffer W.J. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 27 6 (2007) 1405-1410
22. Lippa C.F., Fujiwara H., Mann D.M.A., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., St. George-Hyslop P., Ghetti B., Nochlin D., et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153 (1998) 1365-1370
23. Lippa C.F., Smith T.W., and Perry E. Dementia with Lewy bodies: Choline acetyltransferase parallels nucleus basalis pathology. J. Neural Transm. 106 (1999) 525-535
24. Lippa C.F., Schmidt M.L., Trojanowski J.Q., and Lee V.M.Y. Alpha-synuclein and familial Alzheimer's disease: Epitope mapping parallels DLB and Parkinson's disease. Arch. Neurol. 58 (2001) 1817-1820
25. Lippa C.F., Boeve B.F., Parisi J.E., and Keegan B.M. A 75-year-old man with cognitive impairment and gait changes. Neurology 69 11 (2007) 1183-1189
26. Lippa C.F., Duda J.E., Grossman M., Hurtig H.I., Aarsland D., Boeve B.F., Brooks D.J., Dickson D.W., Dubois B., Emre M., Fahn S., Farmer J.M., et al., DLB/PD-D Working Group. DLB and PD-D boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68 11 (2007) 812-819
27. McKeith I.G., and Mosimann U.P. Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat. Disord. 10 Suppl. 1 (2004) S15-S18
28. McKeith I., Fairbaim A., Perry R., et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 305 (1992) 673-678
29. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies: Report of the consortium on DLB international workshop. Neurology 47 5 (1996) 1113-1124
30. McKeith I.G., Perry R.H., Fairbairn A.F., Jabeen S., and Perry E.K. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol. Med. 22 (1992) 911-922
31. McKeith I., Mintzer J., Aarsland D., et al. Dementia with Lewy bodies. Lancet Neurol. 3 (2004) 19-28
32. McKeith I.G., Dickson D.W., Lowe J., et al. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65 12 (2005) 1863-1872
33. Mormont E., Laurier-Grymonprez L., Baisset-Mouly C., and Pasquier F. The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease. Rev. Neurol. 159 8-9 (2003) 762-766
34. Mosimann U.P., Rowan E.N., Partington C.E., Collerton D., Littlewood E., O'Brien J.T., Burn D.J., and McKeith I.G. Characteristics of visual hallucinations in Parkinson's disease dementia and dementia with Lewy bodies. Am. J. Geriatr. Psychiatry 14 2 (2006) 153-160
35. Mukaetova-Ladinska E.B., and McKeith I.G. Pathophysiology of synuclein aggregation in Lewy body disease. Mech. Ageing. Dev. 127 2 (2006) 188-202
36. O'Brien J.T., Firbank M.J., Mosimann U.P., et al. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatr. Res. 139 2 (2005) 79-88
37. Perry E.K., Haroutunian V., Davis K.L., et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 5 (1994) 747-749
38. Rajput A., Dickson D.W., Robinson C.A., et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67 8 (2006) 1506-1508
39. Rockenstein E., Hansen L., Mallory M., et al. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res. 914 (2001) 48-56
40. Rogan S., and Lippa C.F. Alzheimer's disease and other dementias: A review. Am. J. Alzheimers Dis. Other Demen. 17 1 (2002) 11-17
41. Samuel W., Galaski D., Masliah E., and Hanson L.A. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 44-52
42. Samuel W., Caligiuri M., Galasko D., et al. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study. Int. J. Geriatr. Psychiatr. 15 (2000) 794-802
43. Schiesling C., Kieper N., Siedel K., and Kruger R. Review: Familial Parkinson's disease-Genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol. Appl. Neurobiol. 34 3 (2008) 255-271
44. Walker Z., Allen R.L., Shergill S., and Katona C.L. Neuropsychological performance in Lewy body dementia and Alzheimer's disease. Br. J. Psychiatr. 170 (1997) 156-158